These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6399108

  • 21. Proceedings: Endothelial and smooth muscle cells as antagonists in vascular fibrinolysis.
    Noordhoek Hegt V.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):608. PubMed ID: 1198532
    [No Abstract] [Full Text] [Related]

  • 22. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA, Strukova SM, Kudriashov BA.
    Vopr Med Khim; 1984 Nov 15; 30(2):95-100. PubMed ID: 6540008
    [Abstract] [Full Text] [Related]

  • 23. [Plasminogen activators and their physiological role].
    Andreenko GV.
    Ukr Biokhim Zh (1978); 1983 Nov 15; 55(3):329-43. PubMed ID: 6346623
    [No Abstract] [Full Text] [Related]

  • 24. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 15; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 25. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.
    Verheijen JH, Mullaart E, Chang GT, Kluft C, Wijngaards G.
    Thromb Haemost; 1982 Dec 27; 48(3):266-9. PubMed ID: 6891841
    [Abstract] [Full Text] [Related]

  • 26. Homocystinemia. Vascular injury and arterial thrombosis.
    Harker LA, Slichter SJ, Scott CR, Ross R.
    N Engl J Med; 1974 Sep 12; 291(11):537-43. PubMed ID: 4212055
    [No Abstract] [Full Text] [Related]

  • 27. [Plasminogen activator inhibitors].
    Swiatkowska M, Wilczyńska M, Cierniewski CS.
    Postepy Biochem; 1991 Sep 12; 37(3-4):139-45. PubMed ID: 1812471
    [No Abstract] [Full Text] [Related]

  • 28. [Fibrinolysis modulators].
    Machovich R.
    Orv Hetil; 2002 Mar 17; 143(11):541-5. PubMed ID: 12583322
    [Abstract] [Full Text] [Related]

  • 29. [The regulation of fibrinolysis].
    Matsuo O.
    Nihon Rinsho; 1989 Apr 17; 47(4):739-45. PubMed ID: 2526261
    [No Abstract] [Full Text] [Related]

  • 30. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 17; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 31. Fibrinolysis: molecular mechanism and pathophysiological aspects.
    Lijnen HR.
    Sangre (Barc); 1984 Sep 17; 29(4-C):755-61. PubMed ID: 6240123
    [No Abstract] [Full Text] [Related]

  • 32. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH, Diamond SL.
    J Clin Invest; 1995 Jun 17; 95(6):2483-90. PubMed ID: 7769094
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D, Lijnen HR.
    Thromb Haemost; 1995 Jul 17; 74(1):167-71. PubMed ID: 8578451
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV, Shimonaeva EE, Liutova LV, Serebriakova TN.
    Vopr Med Khim; 1981 Feb 28; 27(1):77-80. PubMed ID: 7193381
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.